Note Payable	3 Months Ended
Dec. 31, 2022
Notes Payable [Abstract]
NOTE PAYABLE	5. NOTE PAYABLE On May 15, 2022, the Company entered into a one-year Directors and Officers Liability Insurance agreement for $89,242. Under the terms of the agreement, the Company made a down payment of $10,210, with the remaining balance financed over the remaining term at an annual percentage rate of 7.328%. Beginning in May 2022, the Company is making 8 monthly payments of $10,210, with the last payment made in December 2022. At December 31, 2022, the note was fully paid. The interest expense for the three months ending December 31, 2022 was $186.

Note Payable

3 Months Ended

Dec. 31, 2022

5. NOTE PAYABLE

On May 15, 2022, the Company entered into a one-year Directors and Officers Liability Insurance agreement for $89,242. Under the terms of the agreement, the Company made a down payment of $10,210, with the remaining balance financed over the remaining term at an annual percentage rate of 7.328%. Beginning in May 2022, the Company is making 8 monthly payments of $10,210, with the last payment made in December 2022. At December 31, 2022, the note was fully paid. The interest expense for the three months ending December 31, 2022 was $186.

Rasna Therapeutics Inc. 10-Q